GLUE- 9.50 area Monte Rosa Therapeutics IR Website Dave's Note: Also a current SRP swing trade with a 12.40 target or 30% from current pricing, long term this appears severely undervalued and a likely buyout, that is our target...

Cassava Science-  SAVA $30.40 1.5 Billion Market Cap Alzheimers Phase 3 play A much talked about and perhaps even maligned Biotech that is on the verge of potentially releasing mind blowing Phase 3 results for Alzheimers indication.  Recently appointing a new CEO with a very strong pedigree and...

New Idea I'm suggesting now All of these I will place a stop loss point on and general target. ASTS- $23 Buy from 21-25.  Near term 28 target but long term potentially much higher. I will provide more details soon. This is an emerging "Space" cellphone service worldwide potential...

Adding some new names to the portfolio today.  The market is pulling back some, offering initial entries into some names I've been watching. The strong themes now are obviously Artificial Intelligence, Data Centers, Power Generation, High Powered Computer hosting, and some other sectors obviously. We only have...

A few new names  to add to the TPS portfolio.  I'm going to keep these very simple because we are looking for our usual 40-100% upside potential over 6-18 months (Lately has been just months) and we will set buy ranges to accumulate on each...

PODC - Podcast One $1.80 Max entry $2 add on dips to $1.60 possible, Target is $3-$5 in 6-12 months INVESTOR DECK  (Suggested reading PDF Download) WEBSITE  PodcastOne (Nasdaq: PODC) is a leading advertiser-supported podcast company offering a 360-degree solution for both content creators and advertisers. Shares of PodcastOne (“PODC) common...

CRSP 61.50- New Position  Target 93 plus  Side Notes first: HIMS at 8.83, continues to look great and we are holding.  TGTX over 17 also looks great up 60% or so for us, still holding. MEEC at 90 cents consolidating, waiting on likely more settlements in February...

TGTX 10.80   Buy down to 10 and up to 11 Target 22-24 possible We bought this in the 15-17 ranges and sold at 22 and 30-31 ranges for nice profits.  The stock then worked all the way down in the market correction and ongoing Biotech Bear Cycle...

ODD- Oddity Tech--- $38 area ODDITY is a consumer tech company that builds and scales digital-first brands to disrupt the offline-dominated beauty and wellness industries. The company serves over 40 million users with its AI-driven online platform, deploying data science to identify consumer needs, and developing...

indian xxnx horny desi indian cheating slime wife show boobs in webcam.